Overexpression of c-Myc results in transformation and multiple other phenotypes, and is accompanied by the deregulation of a large number of target genes. We previously demonstrated that peroxiredoxin 1 (Prdx1), a scavenger of reactive oxygen species (ROS), interacts with a region of the c-Myc transcriptional regulatory domain that is essential for transformation. This results either in the suppression or enhancement of some c-Myc functions and in the altered expression of select target genes. Most notably, c-Myc-mediated transformation is inhibited, implying a tumor suppressor role for Prdx1. Consistent with this, prdx1À/À mice develop age-dependent hemolytic anemias and/or malignancies. We now show that erythrocytes and embryonic fibroblasts from these animals contain higher levels of ROS, and that the latter cells show evidence of c-Myc activation, including the ability to be transformed by a ras oncogene alone. In contrast, other primary cells from prdx1À/À mice do not have elevated ROS, but nonetheless show increased oxidative DNA damage. This apparent paradox can be explained by the fact that ROS localize primarily to the cytoplasm of prdx1 þ / þ cells, whereas in prdx1À/À cells, much higher levels of nuclear ROS are seen. We suggest that increased DNA damage and tumor susceptibility in prdx1À/À animals results from this shift in intracellular ROS. prdx1À/À mice should be useful in studying the role of oxidative DNA damage in the causation of cancer and its prevention by antioxidants. They should also help in studying the relationship between oncogenes such as c-Myc and DNA damage.
Introduction
Deregulation of the C-MYC oncogene, which encodes a general transcription factor of the basic-helix-loophelix-leucine zipper family, is among the most commonly encountered molecular aberrations in human cancer. A variety of mechanisms account for the loss of C-MYC control (Nesbit et al., 1999; www.myc-cancergene.org) . For example, C-MYC overexpression in Burkitt's lymphoma is invariably due to chromosomal translocations involving the C-MYC locus on chromosome 8q24 and immunoglobulin genes located on chromosomes 2, 14, or 22 (Boxer and Dang, 2001) . In prostate and breast cancers, a significant fraction of tumors demonstrate amplification of an otherwise unrearranged C-MYC locus (Pietilainen et al., 1995; Bubendorf et al., 1999; Sato et al., 1999; Naidu et al., 2002) . In contrast, the c-Myc mRNA and protein overexpression that is observed in 70-80% of colon carcinomas (Smith and Goh, 1996) results from aberrant transcriptional control of the C-MYC locus involving mutations in APC-b-catenin-TCF-4 pathway members (Barker et al., 2000) .
Apart from its role in tumorigenesis, the proper regulation of C-MYC gene transcription and c-Myc function is important for a variety of normal processes, including cell cycle progression, differentiation, maintenance of cell size, and regulation of programmed cell death (Coppola and Cole, 1986; Prochownik and Kukowska, 1986; Stern et al., 1986; Prochownik et al., 1988; Henriksson and Luscher, 1996; Johnston et al., 1999; Li and Dang, 1999; Prendergast, 1999; Yin et al., 1999 Yin et al., , 2001 Fest et al., 2002; Iritani et al., 2002; Obaya et al., 2002; Schorl and Sedivy, 2003; Maines et al., 2004) . The ability to influence such a broad spectrum of normal functions, and to promote transformation when deregulated, is a consequence of c-Myc's role as a general bHLH-ZIP transcription factor, whose target genes, both positive and negative, currently number well over 1000 (Fernandez et al., 2003; Levens, 2003; Li et al., 2003) . Positive regulation involves the initial binding of c-Myc, in association with its obligate heterodimeric bHLH-ZIP partner protein Max, to consensus binding sites (E-boxes) generally located within 1-2 kb of the transcription initiation site (Grandori et al., 2000; Fernandez et al., 2003; Levens, 2003) . This is then followed by the activation of the bound gene, which is mediated by a transcriptional regulatory domain (TRD) of c-Myc in association with a number of ancillary transcription and chromatin remodeling cofactors (Grandori et al., 2000; Eisenman, 2000-1) . Negative regulation by c-Myc is more diverse but in at least some cases appears to involve c-Myc's association with and inhibition of positive transcription factors such as Miz-1 (Staller et al., 2001; Oster et al., 2003; Wanzel et al., 2003) . All known biological activities of c-Myc require the intactness of its bHLH-ZIP dimerization domain and the TRD (Evan et al., 1994; Xiao et al., 1998; Luscher and Larsson, 1999; Oster et al., 2003) .
The functional dissection of c-Myc's TRD and the proteins with which it interacts have been the subject of intense study (reviewed in Oster et al., 2002) . Several reports have confirmed that a small segment of the TRD, comprised of amino acids 135-150, and termed Myc Box II (MBII), is required for transformation (Li et al., 1994; McMahon et al., 1998) . A number of proteins that interact with the TRD and with MBII, and that reduce or enhance c-Myc's transcriptional activity and/or biological function, have been described (Oster et al., 2002) .
Peroxiredoxin 1 (Prdx1), also known as pag ('proliferation-associated gene') or MSP23 (Ishii et al., 1993; Prosperi et al., 1993) , is a ubiquitously expressed and highly conserved member of a family of antioxidant proteins that utilize thioredoxin as an electron donor (Hofmann et al., 2002; Wood et al., 2003) . In addition to being induced by reactive oxygen species (ROS), PrdxI is also induced by serum stimulation and by RAS oncogene transformation (Prosperi et al., 1993) . By scavenging H 2 O 2 and other ROS, Prdx1 protects cells from oxidant-mediated damage to cellular DNA, lipids and proteins, and from the potentially carcinogenic consequences of the former (Toyokuni, 1999; Mu et al., 2002) . By virtue of its role in maintaining the redox state in vivo, Prdx1 and other members of the Prdx family, may also serve to regulate normal growth factor signaling pathways .
We have previously shown that Prdx1 interacts specifically with MBII and alters key aspects of c-Myc's function (Mu et al., 2002) . This most likely occurs as the result of a selective ability to modulate c-Myc's transcriptional activity. However, the functional consequences of this interaction are complex. On the one hand, Prdx1 overexpression can mimic certain properties of c-Myc such as the ability to increase the overall mass and size of some cells (Mu et al., 2002) . On the other hand, Prdx1 overexpression substantially reduces the in vitro clonogenic growth and in vivo tumorigenic capacity of c-Myc-transformed fibroblasts. This latter property, together with the previously described ability of Prdx1 to inhibit the tyrosine kinase activity of the c-Abl oncoprotein (Wen and Van Etten, 1997) , led us to postulate that Prdx1 might represent a new class of tumor suppressors (Mu et al., 2002) . Although the interaction between MBII and Prdx1 has been demonstrated in vivo, it remains unclear as to whether Prdx1's effects on c-Myc function are the direct result of its interaction with MBII.
A mouse strain lacking Prdx1 has recently been described (Neumann et al., 2003) . These animals, although viable and fertile, develop a variety of agerelated cancers and/or Heinz body-positive hemolytic anemia. The latter is associated with an increase in erythrocyte ROS, and a high level of oxidized, unstable hemoglobin, which probably contributes to a shortened red cell lifespan. Taken together, these results are consistent with the notion that, by scavenging ROS, Prdx1 limits oxidative damage to various macromolecules.
We have independently developed a mouse strain lacking Prdx1 as a result of retroviral-mediated mutational inactivation. We now report that primary embryonic fibroblasts from these animals contain higher levels of ROS and show evidence of c-Myc deregulation. This includes changes in growth rate, cell size, susceptibility to RAS oncogene-mediated transformation, and alterations in c-Myc target gene expression. Other primary tissues from prdx1À/À mice contain significantly higher levels of oxidatively damaged DNA as determined by liquid chromatography/mass spectroscopy (LC/MS) and gas chromatography/mass spectroscopy (GC/MS). Although the total levels of ROS are not altered in most tissues from prdx1À/À mice, they do show dramatic shifts in their subcellular localization, which might account for the greater degree of DNA damage. Taken together, these results provide evidence for a global increase in oxidative DNA damage in tissues from prdx1À/À mice due to abnormal localization of ROS.
Results

Derivation of prdx1À/À mice
Derivation of prdx1 gene 'knockout' mice was performed in collaboration with Lexicon Genetics Incorporated. This approach capitalized on the well-known tendency of murine retroviruses to integrate at diverse sites in the genome, resulting, in some cases, in insertional inactivation of genes (Robertson et al., 1986; Mikkers and Berns, 2003) . Sequencing of the genomic regions flanking several thousand viral integration sites from independently infected clones revealed that the prdx1 locus had been targeted on several occasions (not shown). One such banked ES clone was therefore used to generate mice heterozygous for this insertion. Figure 1 shows the structure of the murine prdx1 gene, the site of integration of the mutagenic retrovirus, the strategy used to identify the three possible genotypes, results of genetic analyses of one group of mice, and Northern and western blots of Prdx1 expression. These results showed perfect correlation between genotypes and Prdx1 mRNA and protein expression, and confirmed that prdx1À/À and prdx1 þ /À mice were viable and fertile.
Characterization of primary embryo fibroblasts from prdx1À/À mice Primary embryo fibroblasts murine embryonic fibroblasts (MEFs), derived from E10.5 prdx1 þ / þ or À/À embryos, were studied between passages 2 and 5. As shown in Figure 2a , prdx1À/À cells grew at a significantly slower rate than did their prdx þ / þ counterparts. However, cells of both genotypes showed identical cell cycle profiles (Figure 2b ) as well as low and indistinguishable rates of apoptosis (o10% in all cases) as determined by TUNEL and trypan blue exclusion assays and by quantification of subdiploid DNA content by flow cytometry (not shown). Additional studies performed with cells synchronized in Go by density arrest showed that, upon replating at low density, prdx1À/À cells traversed all phases of the subsequent cell cycle with a lag of 3-5 h compared to their prdx1 þ / þ counterparts (not shown). Taken together, these results indicate that the slower growth rate of prdx1À/À cells was not attributable to a block of cell cycle progression at any specific point or to intrinsic differences in basal apoptotic rates.
We have previously shown that, like c-Myc, Prdx1 overexpression can increase the size of certain established cell types (Mu et al., 2002) . If this held true for MEFs, then prdx1À/À cells would be predicted to be smaller than prdx1 þ / þ cells. To examine this, we determined the average cellular diameters of the two MEF populations. As seen in Figure 2c , prdx1À/À MEFs were indeed significantly smaller than prdx1 þ / þ cells. When the diameters of the two populations were used to calculate volumes, prdx1À/À cells were, on average, nearly 40% smaller than prdx1 þ / þ cells. Genotyping of an eight-pup litter from prdx1 þ /À parents. The first panel depicts the amplification products of the endogenous prdx1 locus, using PCR primers 1 and 2 (Endog. Prdx1). The second panel depicts the amplification products of the retrovirally targeted prdx1 locus using PCR primers 2 and 3 (LTR-Prdx1). Note that lanes 5 and 8 show the presence of Endog-Prdx1 products only, indicating prdx1 þ / þ animals. Lane 6 shows an absence of the Endog-Prdx1 product and the presence of an LTRPrdx1 product, thus indicating a prdx1À/À genotype. Lanes 1-4 and 7 show the presence of both PCR products, indicating prdx1 þ /À animals. Lane 9 served as a control lane for each PCR reaction with no added genomic DNA. (c) Northern analyses of liver RNAs from each of the three genotypes shown in (a). A membrane containing 5 mg of total liver RNA was hybridized with a Prdx1 coding region probe (upper panel). The lower panel shows the ethidum bromide-stained membrane prior to hybridization. (d) Western analyses of total protein from livers of mice of the indicated genotypes. In all, 25 mg of total protein was subjected to SDS-PAGE and transfer. The membrane was probed with a rabbit polyclonal antibody raised against murine Prdx1 (left-most panel), or an anti-actin monoclonal antibody as a control for protein loading (right-most panel)
The increased cell volume that accompanies Prdx1 overexpression also results in an increase in total protein content (Mu et al., 2002) . Therefore, to confirm the above results, the total protein content from comparable numbers of prdx1 þ / þ and prdx1À/À cells was determined. As seen in Figure 2d , the latter cells contained, on average, 62% of the protein of prdx1 þ / þ cells, which is in excellent agreement with the previously described cell volume determinations We next measured the levels of ROS in logarithmically growing MEFs, either under basal conditions or following a 6 h challenge with a sublethal dose (35 mM) of H 2 O 2 . ROS were quantified by measuring the amount of intracellular CM-H 2 DCFDA that is cleaved by Figure 2 Characterization of MEFs. (a) Growth rates of prdx1 þ / þ and prdx1À/À MEFs. Cultures at passage 2-3 were seeded in triplicate into 35 mm wells on day 0. Growth medium was changed every 3-4 days. At the indicated times, cells were trypsinized and the total number of viable cells per plate was determined. Asterisks indicate significant differences between prdx1 þ / þ and prdx1À/À cell numbers (Po0.05). TUNEL assays showed no differences in the rates of apoptotic death, which in both cases were o10% (not shown). (b) Cell cycle profiles of prdx1 þ / þ and prdx1À/À cells. Logarithmically growing MEFs were stained with propidium iodide, and the fraction of cells in G0/G1, S, and G2/M was determined by flow cytometry as previously described (Yin et al., 1999) . The results shown depict the averages of six determinations for each genotype. Standard errors in all cases were o2%. (c) Size determinations of MEFs. The sizes of logarithmically growing MEFs of each of the indicated genotypes were determined using a Vi-Cell Cell Viability Analyzer. prdx1À/À cells were smaller than prdx1 þ / þ cells by a highly significant margin (Po10
Relative protein content of prdx þ / þ and prdxÀ/À MEFs. Triplicate aliquots of 3 Â 10 6 cells of each genotype were washed three times in PBS, followed by sonication and boiling in PBS þ 0.1% SDS. Total protein content was determined using the BCA reagent as previously described (Mu et al., 2002) . (e) ROS levels in MEFs. Uptake of CM-H 2 DCFDA was determined in logarithmically growing MEFs, either untreated or following exposure to 35 mM H 2 O 2 for 30 min. The results shown represent the average of triplicate determinations 7 1s.e. All results are compared relative to untreated prdx1 þ /À MEFs whose ROS levels were arbitrarily set at 1 intracellular esterases and rendered fluorescent under oxidizing conditions (Yuan et al., 1993) . As seen in Figure 2e , untreated prdx1 þ / þ cells contained low levels of ROS, which increased dramatically following exposure to H 2 O 2 . In contrast, prdx1À/À cells did not show a significant increase in ROS, possibly owing to the fact that basal levels were already very high. This suggests that there is an upper limit to ROS levels that can be generated in Prdx1's absence.
Susceptibility of prdx1À/À MEFs to ras transformation
We have previously shown that Prdx1 overexpression significantly reduces the in vitro clonogenic growth and in vivo tumorigenicity of c-Myc-transformed fibroblasts (Mu et al., 2002) . We proposed that this results from Prdx1's interaction with the MBII region of c-Myc's TRD. These results, together with more recent studies (Neumann et al., 2003) , indicated that Prdx1 might function as a tumor suppressor. This further suggested that a consequence of Prdx1 loss in primary cells might be the functional deregulation of endogenous c-Myc protein.
Primary embryonic fibroblasts are generally resistant to transformation with individual c-Myc or ras oncogenes but can be readily transformed when the two are coexpressed (Parada et al., 1985; Land et al., 1986) . We therefore reasoned that if c-Myc were indeed deregulated in prdx1À/À MEFs, they might be susceptible to transformation by a Ras oncogene alone. Monolayer cultures of prdx1 þ / þ and prdx1À/À MEFs were therefore infected with a retroviral vector encoding mutant v-Ha-ras oncogene, together with a 1 : 1 mix of a control vector encoding GFP that had been packaged in parallel. The latter vector served as a direct visual means of comparing the infection efficiencies of the two cell types. As seen in Figure 3a and b, endogenous c-Myc RNA and protein were expressed at equivalent levels in both prdx1 þ / þ and prdx1À/À cells. However, the latter were easily transformed following infection with a retrovirus encoding a mutant (G12V) v-Ha-ras oncogene (Figure 3c -e). In contrast, prdx1 þ / þ cells were resistant to v-H-ras transformation, despite the fact that they were infected approximately 2-3 times more efficiently than prdx1À/À cells based on GFP fluorescence (not shown). In other experiments, we have shown that these ras expressing cells form anchorage-independent colonies in soft agar, although with only about 10% the efficiency with which they form adherent foci (not shown). Taken together, these results are consistent with our previous suggestion that Prdx1 loss results in a deregulation of c-Myc function without altering its levels (Mu et al., 2002) .
The interaction between the MBII domain of c-Myc and Prdx1 can lead to the altered expression of some, but not all, c-Myc target genes (Mu et al., 2002) . To determine whether this was also true in MEFs, we compared the gene expression profiles of several previously described c-Myc targets in prdx1 þ / þ and prdx1À/À MEFs by Northern blotting. As seen in Figure 3f , differences in the transcript levels of several of these genes were indeed identified. In particular, prdx1À/À cells showed lower levels of expression of the positive c-Myc targets cyclin B1, Id2, ODC, and HMG-IY (Yin et al., 2001; Lasorella et al., 2000; Wood et al., 2000) , whereas they showed higher levels of expression of the negative target gadd45 (Marhin et al., 1997) . A second negative target, Gas1 (Lee et al., 1997) , was expressed at higher levels in wild-type than in prdx1À/À cells. Finally, two additional positive targets, LDH-A and a1-prothymosin (Eilers et al., 1991; Shim et al., 1997) , showed no differences in expression between the two cell lines. These results lend further support to the idea that Prdx1 deficiency is associated with the deregulation of c-Myc, leading to a failure to properly regulate a subset of its target genes.
Prdx1 controls ROS levels in some tissues
The finding that prdx1À/À MEFs contain higher levels of ROS (Figure 2e) is consistent with the notion that Prdx1 protects against oxidative stress. However, because these cells had been maintained in a highly oxidative in vitro environment (Parrinello et al., 2003) , it was not clear whether these finding necessarily reflected the true in vivo state of all tissues. In order to explore this in more depth, we measured ROS levels in several additional tissues, including erythrocytes, splenocytes, and hepatocytes. The former were chosen because of the documented hemolytic anemias that develop in some prdx1À/À animals beginning at approximately 9 months of age, whereas splenocytes and hepatocytes were examined because of the high incidence of lymphomas and hepatocellular carcinomas (Neumann et al., 2003) . ROS determinations were performed on erythrocytes obtained by peripheral venous sampling from agematched, nonanemic animals. That nonanemic animals were used was a particularly important consideration, as elevated ROS levels in anemic animals could be a secondary consequence of membrane damage and thus might not provide an accurate assessment of the role of Prdx1. For ROS determinations in hepatocytes and splenocytes, animals were also age-matched (1.5-7 months), and showed no evidence of neoplasms. As seen in Figure 4 , basal levels of ROS were 27% higher in erythrocytes from prdx1À/À animals (Po0.001), whereas no significant differences were observed in either splenocytes or hepatocytes. Interestingly, the relative ROS increase in prdx1À/À erythrocytes was relatively constant and age-independent, indicating that factors other than Prdx1 loss contribute to the onset of hemolytic anemia.
DNA damage in prdx1À/À mice
High levels of ROS are associated with increased intracellular oxidation of lipids, proteins, and nucleic acids. If not repaired, oxidatively modified DNA bases can generate heritable and cancer predisposing mutations (reviewed in Marnett et al., 2003) . The high incidence of neoplasms in prdx1À/À mice (Neumann et al., 2003) is consistent with the idea that the tumors arise as a consequence of lifelong oxidative assault upon the genome with the final outcome reflecting the balance between DNA damage and its repair. Similarly, the development of Heinz body-positive hemolytic anemias is consistent with the idea that high levels of ROS in erythrocytes lead to oxidation and precipitation of hemoglobin, membrane damage, and premature destruction of the cell.
We used both LC/MS and GC/MS to measure the levels of oxidatively modified DNA nucleosides in three different tissues from prdx1 þ / þ and prdx1À/À mice. As discussed in the previous section, the spleen and liver were chosen because of the high incidence of tumors arising from these organs, whereas brain was selected because central nervous system malignancies are rarely, if ever, encountered (Neumann et al., 2003) . In all cases, we evaluated the same animals as used for the previously described ROS determinations. For each data point, tissues from three different animals were used. Figure 5 shows the average levels of modified DNA nucleosides from these two groups of animals. From these analyses, as well as from the data shown in Figure 4 , several points are apparent. First, each prdx1À/À tissue demonstrated a signature DNA damage profile. For example, we found twice as much 8-OH-dG in liver DNA samples than in spleen samples, whereas twice as much (5 0 S)-dG was observed in spleen DNAs than in liver DNAs. Second, although we were unable to (f) Northern analyses of RNAs from prdx1 þ / þ and prdx1À/À MEFs. Total RNAs were extracted from MEFs that had been grown in parallel under identical conditions. 5 mg of each sample was then used in Northern blot analyses using coding region probes for the indicated c-Myc target genes. Hybridization with a probe for GAPDH was used as a control for RNA loading. The numbers adjacent to each blot represent the relative level of expression of that transcript following normalization to the GAPDH control demonstrate significant differences in ROS levels between the two groups of animals (excluding erythrocytes and MEFs), the levels of specific modified DNA nucleosides were often significantly higher in prdx1À/À animals than in prdx1 þ / þ animals although again, these differences were both DNA base-and tissuespecific. Third, no single modified DNA nucleoside was necessarily predictive of the levels of the other five. Finally, even though central nervous system tumors are rare in prdx1À/À mice (Neumann et al., 2003) , substantially higher levels of modified nucleoside bases were nonetheless detected in their brain DNAs. From these studies, we conclude that Prdx1 loss results in a significant accumulation of oxidatively modified DNA nucleosides in genomic DNA of at least three different tissues of prdx1À/À mice. They also indicate that there exist tissue-specific differences in the generation and/or repair of each type of lesion and that tumor susceptibilty does not simply reflect overall levels of DNA damage.
Loss of Prdx1 might compromise the integrity of DNA repair, either through c-Myc or c-Abl-dependent pathways or through pathways which were independent of these oncoproteins (Shaul, 2000; Hironaka et al., 2003; Karlsson et al., 2003) . This might explain why prdx1À/À tissues demonstrate higher levels of DNA damage in the absence of elevated ROS. 8-OH-dG (and possibly 8-OH-dA) is repaired by base-excision (BE) (reviewed in Cooke et al., 2003) , whereas (5 0 S)-cdA is repaired by nucleotide excision (NE) (Brooks et al., 2000; Kuraoka et al., 2000) . Other cyclopurine-2 0 -deoxynucleosides such as (5 0 R)-cdA, (5 0 R)-cdG, and (5 0 S)-cdG are also likely to be processed by NE because of a covalent bond between the sugar and base moieties of the same nucleoside, thus excluding repair by BE (Dizdaroglu, 1986) . However, we have found equivalent activities of uracil DNA glycosylase, oxoguanine DNA glycosylase, and endonuclease III homologue I in prdx1 þ / þ and prdx1À/À liver and kidney extracts (data not shown) (de Souza-Pinto et al., 2001; Karahalil et al., 2003) . These findings therefore do not account for the higher levels of DNA damage in prdx1À/À mice.
Subcellular re-distribution of ROS in prdxÀ/À tissues
The foregoing results presented an apparent paradox; namely, how could prdx1À/À tissues contain higher levels of damaged DNA yet demonstrate no differences in either ROS levels or DNA repair? One possible explanation was that prdx1À/À tissues might differ in their subcellular distribution of ROS. Thus, higher levels of ROS in prdx1À/À nuclei might generate more DNA damage even though total cellular ROS levels were equivalent to those in prdx1 þ / þ cells. To examine this directly, logarithmically growing MEFs, or single-cell suspensions from the lung, kidney, and liver were incubated briefly with CM-H 2 DCFDA, fixed with paraformaldehyde, and examined by fluorescence microscopy. As seen in Figure 6 , prdx1 þ / þ cells showed a diffuse and largely cytoplasmic pattern of activated CM-H 2 DCFDA whereas prdx1À/À cells showed much more intense nuclear staining. These differences were most striking in MEFs in which there was almost a complete shift of ROS from the cytoplasm to the nucleus. In cells derived from the lung, kidney, and liver of prdx1À/À mice, ROS were also significantly relocalized to the nucleus, although not as strikingly as in the case of MEFs. These findings indicate that Prdx1 loss results in significant shifts in the subcellular localization of ROS ( Figure 6 ).
Discussion
In mammals, the Prdxs comprise a highly conserved family of six proteins. Prdxs1-5 utilize thioredoxin as an electron donor to reduce H 2 O 2 , which may be produced as a result of oxidative stress, carcinogens, environmental toxin exposure, or normal growth factor signaling (Kang et al., 1998) . Significant functional redundancy exists within this family whose members may also regulate cellular growth, differentiation, apoptosis, and transformation (Szatrowski and Nathan, 1991; Pentland et al., 1992; Nakahara et al., 1998; Esposito et al., 1999) . More recently, an unanticipated and novel function for yeast Prdx1 and Prdx2 in response to ROS has been described, which involves the formation of high molecular weight toroidal structures by these proteins, which then function as molecular chaperones (Jang et al., 2004) .
The cancer-prone phenotype of prdx1À/À mice is distinctly different from those of knockouts of other genes involved in maintaining the redox state. These latter animals are either susceptible to cancer only upon exposure to exogenous carcinogens or are not tumor prone at all (Henderson et al., 1998; Ramos-Gomez et al., 2001; Lee et al., 2003) . The idea that Prdx1 also plays a central role in integrating potentially harmful, Figure 4 ROS in primary tissues of prdx1 þ / þ and prdx1À/À mice. Animals of the indicated genotypes were killed in parallel and single-cell suspensions from the indicated organs were prepared as described in 'Materials and methods'. Flow cytometry was used to determine the relative basal levels of ROS following incubation with CM-H 2 DCFDA. In the case of erythrocytes, the values are the averages of 29 prdx1 þ / þ and 32 prdx1À/À animals, all of which were nonanemic and age-matched (1.5-18 months). In the case of hepatocyes and splenocytes, the values are the averages of five animals/group. Standard error bars and significant P-values, as determined by Student's t-test are indicated but critically important, proliferative signals is supported by the observation that it can interact with and modulate the activities of two key cellular oncoproteins, c-Abl and c-Myc (Wen and Van Etten, 1997; Mu et al., 2002) .
Our prior observation that Prdx1 overexpression could mimic the growth-promoting activity of c-Myc while simultaneously inhibiting its transforming potential (Mu et al., 2002) is independently confirmed in the current work. The finding that prdx1À/À MEFs are susceptible to ras transformation, despite possessing unaltered levels of c-Myc RNA and protein (Figure 3a-c) is consistent with our previous proposal that some, although not necessarily all, c-Myc functions are modulated by Prdx1 (Mu et al., 2002) . One such function is that of transformation, which can be induced in prdx1À/À MEFs via the action of an activated ras oncogene alone. In addition to producing foci under low serum conditions (Figure 3d ), these cells can also form anchorage-independent colonies in soft agar, albeit with a 90% reduced efficiency compared to focus formation (not shown). This suggests that the massive c-Myc deregulation that is necessary to achieve efficient anchorage-independent growth (Land et al., 1986) has not been achieved in prdx1À/À cells, which express normal levels of c-Myc mRNA and protein (Figure 3a and b). Selective alteration of c-Myc function and target gene regulation has subsequently been described for other proteins that bind to specific subregions of the cMyc transcriptional regulatory domain including MBII (Nikiforov et al., 2002; Qi et al., 2004) . Similarly, the smaller size, reduced growth rate, and altered expression of a subset of c-Myc target genes in prdx1À/À MEFs (Figures 2 and 3 ) is also consistent with the idea that Prdx1 controls some c-Myc functions. These findings provide reason to question whether the tumor-prone Figure 5 Basal levels of DNA damage in prdx1 þ / þ and prdx1À/À mouse tissues. Following complete hydrolysis, total cellular DNAs were analyzed by LC/MS and GC/MS in order to quantify the indicated modified DNA nucleosides. Three animals of each group were analyzed, with all animals being between 1.5 and 7 months of age. The mean value of each modified nucleoside is shown, 7 1s.e. Statistically significant P-values, as determined by Student's unpaired t-test, are indicated above the appropriate paired samples nature of prdx1À/À mice is due exclusively to the stochastic accumulation of oxidatively induced mutations or whether c-Myc (and perhaps c-Abl) deregulation may not also contribute to the phenotype. Indeed, the ras sensitivity of prdx1À/À MEFs suggests that, at least in the in vitro environment, transformation per se is not dependent upon the mutational consequences of ROS-mediated DNA damage. Recent findings that elevated intracellular H 2 O 2 is associated with constitutive activation of NF-kB (Kang et al., 1998) and that NF-kB itself is a potential oncogene when deregulated (Hu et al., 2004) suggests that Prdx1 loss may predispose to cancer susceptibility via yet additional and mechanistically distinct DNA damage-independent pathways.
A central finding of our current work is the lack of elevated ROS in prdx1À/À hepatocytes and splenocytes. This, together with the finding that prdx1À/À cells do not possess defective DNA repair activity, raised the question as to why the former contain higher levels of damaged DNA ( Figure 5 ). This question was resolved with the finding that prdx1À/À cells redistribute their ROS, with much higher concentrations localizing to nuclei (Figure 6 ). These findings are consistent with our previous observations that a considerable fraction of prdx1 resides in the nucleus (Mu et al., 2002) and that other ROS scavengers are less able to substitute for Prdx1. As it has been previously shown that the deregulation of c-Myc can lead to ROS generation (Vafa et al., 2002) , it is tempting to speculate that the high levels of ROS seen in the nuclei of prdx1À/À cells is related to the functional deregulation of c-Myc as well as to the loss of ROS scavenging that accompanies prdx1 knockout (Figure 7) .
Another important finding of the current study concerned the tissue-specific nature of oxidative DNA damage. This implies that tumorigenesis in prdx1À/À mice may not be explainable by a simple model in which transformation is directly related to ROS levels, which in turn induce quantitatively and qualitatively identical levels of DNA damage in all tissues. This poor correlation might be explained by the presence of other tissue-specific ROS scavengers, differences in the efficiencies of DNA repair of particular damaged nucleoside species, or by differential levels of deregulated c-Myc or c-Abl.
Of the DNA lesions identified in this work, 8-OH-dG is the most potent mutagen by virtue of its promoting G-T transversions (reviewed in Grollman and Moriya, 1993). 8-OH-dA is also mutagenic in mammalian cells where it generates A-G and A-C alterations (Guschlbauer et al., 1991; Wang et al., 1998) . The abnormal accumulation of these two lesions in at least some tissues of prdxÀ/À animals might contribute to their cancer-prone phenotype (Neumann et al., 2003) . In Figure 6 Relocalization of ROS in prdx1À/À cells. prdx1 þ / þ and prdx1À/À MEFs were grown on glass coverslip for 1-2 days and were then exposed for 30 min to 2.5 mM CM-H 2 DCFDA as described in 'Materials and methods'. Single-cell suspensions from the indicated organs of age-matched prdx1 þ / þ and prdx1À/À mice were prepared as described in 'Materials and methods'. The cells were then resuspended in D-MEM, incubated with 2.5 mM CM-H 2 DCFDA for 30 min and Cytospun onto glass microscope slides. All cells were then fixed in paraformaldehyde and viewed by fluorescence microscopy as previously described (Rothermund et al., 2005) Figure 7 Model depicting the roles of Prdx1 and c-Myc in generating ROS and damaged DNA. Prdx1 normally scavenges ROS, which may be generated by intracellular signaling pathways or by various environmental insults. In prdx1À/À animals, the deregulation of c-Myc itself may independently contribute to the generation of ROS in some tissues (Thorgeirsson et al., 2000; Vafa et al., 2002 ). Prdx1's ability to promote shifts in the subcellular localization of ROS ( Figure 6 ) provides an explanation for the increased DNA damage found in tissues of prx1À/À mice, despite unaltered levels of total ROS. Other factors account for the tissuespecific nature of the type of DNA damage, and its tendency, along with that of c-Myc, to promote neoplastic progression (Vafa et al., 2002; Karlsson et al., 2003) Regulation of ROS and c-Myc function by Prdx1 RA Egler et al contrast, little is known about the biological effects of cyclopurine-2 0 -deoxynucleosides. Recent studies have provided evidence that (5 0 S)-cdA is a cytotoxic lesion, as it was shown to impose a strong block to elongating DNA and RNA polymerases as well as to block the binding of transcription factors to their cognate recognition sequences (Brooks et al., 2000; Kuraoka et al., 2000 Kuraoka et al., , 2001 Marietta et al., 2002) . By inference, (5 0 R)-cdA, (5 0 R)-cdG, and (5 0 S)-cdG may also represent cytotoxic lesions. The mutagenic properties of cyclopurine-2 0 -deoxynucleosides have not yet been investigated. In addition, the question of whether specific combinations of mutagenic bases might cooperate in vivo to promote cancer has not been addressed.
In summary, the results presented here provide evidence for the deregulation of ROS and c-Myc in prdxÀ/À animals. The consequences of this include the inhibition or enhancement of select c-Myc functions pertaining to cell growth, proliferation and susceptibility to oxidative stress and transformation. The current work suggests the existence of a potentially complex relationship among Prdx1 loss, ROS generation and its subcellular localization, tissue-specific DNA damage and cancer susceptibility. It further offers a potentially tractable in vivo model for study of these relationships.
Materials and methods
Prdx1 'knockout' mice and genotyping
Derivation and characterization of prdx1À/À mice was performed in collaboration with Lexicon Genetics Incorporated (The Woodlands, TX, USA). Random retroviral insertional mutagenesis of embryonal stem cells has been previously described (Robertson et al., 1986; Mikkers and Berns, 2003) . Determination of the insertion sites of several thousand clones indicated that the prdx1 locus had been targeted on several independent occasions. One of these clones was used for blastocyst injections and subsequent derivation of an SVJ129/C57Blk6 Prdx1 þ /À breeding pair. Figure 1 depicts the subsequent strategy used for the genotyping of all animals and depicts the retroviral insertion site 128 nt upstream of exon 3 (between nt 1209 and 1210 of the GenBank genomic reference clone no. AF157330). Polymerase chain reaction (PCR) primers spanning nt 921-943 (primer no.1, Figure 1) ) and nt 1485-1509 (primer no. 2) of the murine prdx1 genomic locus and flanking the retroviral insertion were used to amplify 599 bp of the endogenous gene. A third primer (no. 3: 5 0 -AAATGGCGTTACTTAAGCTAG CTTGC-3 0 ), and homologous to a sequence within the retroviral 3 0 -LTR, was used in conjunction with primer no. 2 to amplify 224 bp of sequence that was unique to the insertion site. Control PCR reactions were designed to amplify a 429 bp region of the murine mt-mc1 genomic locus (Yin et al., 2002, GenBank Accession no. AF499468) . All PCR reactions were performed simultaneously using a Perkin-Elmer model 480 thermal cycler. In all, 100 ml reactions consisted of 1 Â PCR Buffer (Promega, Madison, WI, USA), 1.75 mM MgCl 2 , 160 mM of each dNTP, 1.5 mg of each primer, 100 ng of genomic DNA and 5 units of Taq DNA polymerase (Promega). A total of 40 cycles of amplification were performed under the following conditions: 1 min-941C; 1 min-621C; 0.5 min-721C. 20 ml of each reaction were then electrophoresed on 2% agarose gels in 1 X TBE buffer followed by staining with ethidium broide and photographic documentation. Confirmation that the correct loci had been amplified in each case was obtained by demonstrating the presence of restriction enzyme sites at predicted locations within each fragment and/or by hybridization of Southern blotted fragments with radiolabeled oligonucleotides homologous to sequences located between the primer sites (not shown).
Derivation and analysis of primary murine embryonic fibroblasts E11.5 embryos were decapitated and eviscerated. The remaining carcasses were finely minced in PBS-0.25% trypsin (GIBCO-BRL, Grand Island, NY, USA) and incubated at 371C for 30 min with intermittent agitation. After vigorous ticturation, the suspension was passed through a 70 mm mesh filter ('Cell Strainer', BD Biosciences, Bedford, MA, USA) pelleted and resuspended in Dulbecco's-modified Eagle's essential medium (D-MEM) þ 10% fetal bovine serum (FBS, GIBCO-BRL). These cells were designated passage 1. Except where indicated, cells were then maintained on a 3T3-type protocol prior to freezing in liquid nitrogen at passages 2-3. All experiments reported here were performed with cells between passages 2-5.
Growth curves were performed by plating 3 Â 10 4 MEFs of each genotype into 35 mm plates in medium containing 10% serum. Cultures were maintained by replacing growth medium every 3-4 days. The total number of viable cells on succeeding days was determined in triplicate plates by trypsinizing monolayers and determining the cell count of trypan bluestained cells with a hemacytometer. Viability in all cases exceeded 95%.
Cell cycle determinations were performed on MEFs initially seeded at 10 5 cells/well in six-well plates. These were allowed to achieve log-phase growth over the next 2 days, by which time both sets of cultures had achieved 30-50% confluency. Cells were trypsinized, stained with propidium iodide, and immediately subjected to flow cytometry. The fraction of cells in G0/ G1, S, and G2/M was then determined by flow cytometry using a FACS Calibur table top flow cytometer (BectonCoulter) with CellQuest software as previously described (Yin et al., 1999) .
Cell size determinations were performed with a Vi-Cell Cell Viability Analyzer (Model 1.0, Becton-Coulter, Miami, FL, USA). The diameters of at least 6000 log-phase cells were determined on at least five separate occasions and the results were pooled. A video imaging system combined with trypan blue staining was used to exclude nonviable cells, which, in all cases, constituted o5% of the entire population. Size differences were evaluated for statistical significance using Student's t-test. As confirmation for any observed cell size differences, the total protein content of comparable numbers of log-phase cells was determined using the BCA reagent (Pierce, Rockford, IL, USA).
Measurement of ROS in MEFs was performed by quantifying the fluorescence of 5-(and-6)-chloromethyl-2 0 ,7 0 -dichlorodihydrofluorescein diacetate, acetyl ester (CM-H 2 DCFDA, Molecular Probes, Inc., Eugene, OR, USA) (Yuan et al., 1993) . MEFs were plated at 10 5 cells/well in six-well plates and allowed to achieve log-phase growth over the next 2 days. The cells were then either left untreated or were exposed to 35 mM H 2 O 2 for 6 h. Monolayers were washed twice in warm, serumfree D-MEM. The plates were incubated for 30 min at 371C after adding 1 ml of fresh D-MEM containing 2.5 mM CM-H 2 DCFDA. Following brief trypsinization, cells were pelleted at 500 g, washed once in ice-cold PBS, resuspended in 1 ml of cold PBS, and analysed by flow cytometry or by direct visualization by fluorescence microscopy. In the former case, mean CM-H 2 DCFDA fluorescence was determined on triplicate samples, with at least 10 000 events being recorded per sample. CM-H 2 DCFDA has an excitation maximum of 495 nm and an emission maximum of 529 nm. Excitation was achieved with a 488 nm laser wavelength, and read through a 530/30 filter.
Determination of ROS in other primary cells
To measure ROS in peripheral blood erythrocytes, approximately 15 ml of whole blood was obtained from the tail vein of each animal and separated via a 5 min spin at 3000 r.p.m. Erythrocytes were then diluted into 5 ml of phosphate-buffered saline (PBS), pelleted and washed again. Cells were then resuspended in 1 ml of D-MEM containing 2.5 mM CM-H 2 DCFDA and incubated for 30 min at 371C. Fluorescence was then measured as described above for MEFs.
To measure ROS in single-cell suspensions from solid organs, age-matched prdx1 þ / þ and prdx1À/À animals were killed concurrently by cervical dislocation. Organs of interest were removed immediately and finely minced with a razor blade in Hank's basic salt solution (HBSS). Liver and kidney samples were incubated in Type II collagenase (1 mg/ml, Gibco) in HBSS for 90 min at 371C, and then passed sequentially through 70 and 40 mM disposable mesh filters (Falcon, Becton Dickinson). Splenocytes were passed twice through a 70 mM filter and subsequently washed in HBSS. In order to limit red cell contamination of the samples, following the above described isolation procedures, all cell suspensions were centrifuged at 1000 g for 5 min and were resuspended in 20 ml red cell lysis buffer (0.15 M ammonium chloride, 10 mM potassium bicarbonate, 0.1 mM EDTA, pH 7.2) with 3 ml HBSS and 2% FBS for 5 min at room temperature. Following red cell lysis, cell suspensions were again centrifuged and washed once with HBSS. They were then resuspended in warm, serum-free D-MEM containing 2.5 mM CM-H 2 DCFDA and incubated at 371C for 30 min. Cells were then pelleted, washed with ice-cold PBS, resuspended in 0.5 ml of PBS containing 1 mg/ml of propidium iodide, and processed for flow cytometry. At least 2 Â 10 4 cells were evaluated and gated using side and forward scatter to identify live populations. Low PI intensity (o10 2 ) was used to further identify viable cells capable of excluding the dye. This population was further separated into two groups depending on the CM-H 2 DCFDA intensity. For cells with a CM-H 2 DCFDA intensity of at least 10 1 , the mean was determined as described in the previous section.
Isolation of DNA
Genomic DNAs were purified from the same organs used for ROS determinations, with prdx1 þ / þ and prdx1À/À tissues being processed simultaneously. In brief, 100-200 mg of fresh organ fragments were immediately placed into 3 ml of ice-cold lysing solution (500 mM Tris-HCl, pH 8.0; 20 mM EDTA; 10 mM NaCl, 1% SDS and 1.75 mM b-mercaptoethanol). The contents were disrupted for 5 s using a PowerGen 700 tissue homogenizer (Fisher Scientific, Pittsburgh, PA, USA). Proteinase K (Invitrogen, Inc., Carlsbad, CA, USA) was added to a final concentration of 200 mg/ml and the homogenates were incubated overnight at 371C followed by an additional 1-2 h incubation with 10 mg/ml ribonuclease A (Sigma). The digests were then extracted with phenol : chloroform/isoamlyl alcohol that had been equilibrated with 250 mM Tris-HCl and 1.75 mM b-mercaptoethanol followed by an additional extraction with chloroform/isoamyl alcohol only. One-tenth volume of 3 M sodium acetate was then added and the DNA was precipitated by the addition of three volumes of cold absolute ethanol. DNA was spooled, washed with 70% ethanol and allowed to air dry briefly before being redissolved in 0.5 ml of water. The concentration of DNA in aqueous samples was determined by UV spectroscopy (absorbance 1 ¼ 0.05 mg of DNA/ml), and also by GC/MS with acid hydrolysis and isotope-dilution techniques using 2 0 deoxyguanosine-15 N 5 as an internal standard. Upon acid hydrolysis, this compound yields guanine-5 N 5 , which is used as an internal standard for the determination of the guanine content in DNA (Senturker and Dizdaroglu, 1999) . The results obtained by UV spectroscopy and GC/MS were in excellent agreement.
Measurement of oxidative DNA damage
For the measurement of modified nucleosides, DNA samples were hydrolysed to nucleosides using a combination of exo and endonucleases as described previously . N 5 , respectively, as internal standards (Jaruga et al., 2002) .
Retroviral vectors and MEF transformation assays
A pZIPneo retroviral vector encoding a mutant (G12V) Ha-ras oncogene was a gift from Dr Larry Feig (Tufts New England Medical Center, Boston, MA, USA). Retroviral packaging of this or a control vector lacking the ras insert was performed in Phoenix-A cells as previously described (Landay et al., 2000) . Supernatents were harvested 2 days after transfection and were then combined at a 1 : 1 ratio with supernatents from Phoenix-A cells that had been separately transfected with the pBAB-MN-IRES GFP retroviral vector (Landay et al., 2000) . These were then immediately applied to 10 5 prdx1 þ / þ and prdx1À/À MEFs that had been plated in 60 mm dishes the previous day. Infections were allowed to proceed for 4 h in the presence of 8 mg/ml Polybrene (Sigma). Immediately after infection, plates were washed twice in D-MEM-10% FBS and then incubated in the same medium for an additional 2 days. The serum content of the medium was then reduced to 1% for the duration of the experiment with medium being changed every 3-4 days. Parallel plates examined at this time for the expression of green fluorescent protein (GFP) indicated that prdx þ / þ MEFs were infected approximately 2-3 times as efficiently as their prdxÀ/À counterpart MEFs. After 12-14 days, transformed colonies were stained with 2% methylene blue-50% methanol and enumerated.
Northern and Western analyses
RNA purification and Northern blotting has been previously described (Yin et al., 1999 Mu et al., 2002) . All blots contained 5 mg of total RNA per lane. Probes consisted of a 32 P-labeled fragment of murine Prdx1 containing the entire coding region or coding region probes for the indicated c-Myc target genes. Quantification of each transcript was performed with an AlphaImager 2200 (Alpha Innotech Corp., San Leandro, CA, USA) following normalization of GAPDH control signals. Western blotting was performed as previously described using 50 mg of total protein/lane. Western blots of whole-liver lysates were probed with a rabbit polyclonal antibody against Prdx1, which was a generous gift from Dr Soo Goo Rhee (National Institutes of Health).
